Skip to main content

Table 2 NE types

From: Annotation and detection of drug effects in text for pharmacovigilance

Entity type Description Examples
Pharmacological_substance Pharmacological substance that may or may not be approved for human use Genes/gene products used as therapeutic agents Echistatin
Generic drug names Didanosine
IUPAC and IUPAC-like chemical names of drugs 5-hydroxy- l -tryptophan
Endogenous substances administered as exogenous drugs Insulin
Toxins 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine
Excipients Isopropyl myristate
Generic or chemical names of metabolites Threohydrobupropion
Drug brand names DIAMOX
Names of groups of drugs Fluoroquinolones
Expressions characterising general classes of drugs Dopamine D1 receptor antagonist
Disorder Observation about a medical subject’s body or 
mind
 that
 is considered 
to be abnormal 
or caused 
by 
a
 disease, pharmacological substance or DDI Medical conditions Pulmonary embolism
Abnormality in physiological function Hyperlocomotion
Pathological process Fibrosis
Neoplastic process Intestinal adenocarcinomas
Damage caused by disease or drugs Cerebellar damage
Mental
 or
 behavioural 
issue Drug abuse
Injury 
or
 poisoning Clinical toxicities
Viruses/bacteria Micrococcus luteus
Sign or symptom Nausea
Abnormality in clinical attributes or measurements Increased urine sodium
Subject An organism, cell line, bacterium or group thereof, whose characteristics are under discussion. The organism may be human or otherwise General references to groups of subjects Children
Names of specific species under discussion Mice
Names of bacteria under discussion Klebsiella oxytoca
Expressions that specify a number of subjects 16 patients
Descriptions of subject characterstics 50-year old male patient